C12N 2760/18423
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/18423 (Virus like particles [vlp]) appears on 7 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 9
- Assignees
- 9
- Inventors
- 31
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 2 | 1 |
| 2023 | 0 | 0 |
| 2024 | 2 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Targeting PD-L1 on tumor cells12 Aug 2025US 12,384,846 B2Mayo Foundation for Medical Education and Research
- Lassa vaccine7 May 2024US 11,976,305 B2Centre National De La Recherche Scientifique
- Recombinant measles virus expressing zika virus prM and E proteins2 Jan 2024US 11,857,616 B2Centre National De La Recherche Scientifique
- Targeting PD-L1 on tumor cells16 Aug 2022US 11,414,491 B2Mayo Foundation for Medical Education and Research
- Method for producing self-assembling paramyxoviral nucleocapsid-like particles and their uses3 May 2022US 11,319,350 B2Centre National De La Recherche Scientifique
- Liquid-liquid phase separation (llps)-based compartments comprising a short peptide and an anionic polymer12 Jun 2025US 2025/0186360 A1Ramot at Tel-Aviv University Ltd.
- Targeting pd-l1 on tumor cells15 Dec 2022US 2022/0396625 A1Mayo Foundation for Medical Education and Research
- Integrated manufacturing and chromatographic system for virus production19 Aug 2021US 2021/0254021 A1Themis Bioscience GmbH
- Lassa vaccine1 Oct 2020US 2020/0308555 A1Centre National De La Recherche Scientifique
- Recombinant measles virus expressing zika virus proteins and their applications30 Jul 2020US 2020/0237893 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Virus-like particles as vaccines for paramyxovirus12US 7,951,384 B2University of Massachusetts · 2011
- Virus-like particles as vaccines for paramyxovirus5US 9,399,059 B2University of Massachusetts · 2016
- Targeting PD-L1 on tumor cells3US 11,414,491 B2Mayo Foundation for Medical Education and Research · 2022